Results 271 to 280 of about 64,427 (282)

Pneumatosis intestinalis and imatinib mesylate

Annals of Hematology, 2014
Fiona McElligott, Owen P. Smith, Ciara O'Rafferty, Aengus O'Marcaigh, Lorna Storey   +4 more
openaire   +2 more sources

A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients

Cancer Chemotherapy and Pharmacology, 2015
J. Francis, B. Dubashi, R. Sundaram, S. Pradhan, A. Chandrasekaran   +4 more
semanticscholar   +1 more source

The new era of imatinib mesylate

Leukemia Research, 2004
Kazuma Ohyashiki, John M. Goldman
openaire   +2 more sources

Pseudoporphyria induced by imatinib mesylate

International Journal of Dermatology, 2013
Nerea Ormaechea Pérez, Susana Vildósola Esturo, Anna Tuneu Valls, Elena del Alcázar Viladomiu, Ane Jaka Moreno   +4 more
openaire   +2 more sources

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

Nature Network Boston, 2006
Risto Kerkelä, Luanda P Grazette, R. Yacobi, C. Iliescu, R. Patten, Cara Beahm, B. Walters, S. Shevtsov, S. Pesant, F. Clubb, A. Rosenzweig, R. Salomon, R. A. Etten, J. Alroy, J. Durand, T. Force   +15 more
semanticscholar   +1 more source

Hypopigmentation from Imatinib Mesylate (Gleevec)

Journal of Pediatric Hematology/Oncology, 2004
William Grossman, David B. Wilson
openaire   +3 more sources

Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma

Clinical and Experimental Metastasis, 2014
A. Calipel, S. Landreville, A. Fouchardière, F. Mascarelli, M. Rivoire, N. Penel, F. Mouriaux   +6 more
semanticscholar   +1 more source

Imatinib mesylate–induced pseudoporphyria

Journal of the American Academy of Dermatology, 2010
Joseph C. English, Adar T. Berghoff
openaire   +2 more sources

EUTOS CML prognostic scoring system predicts ELN-based ‘event-free survival’ better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Hematology, 2013
B. Uz, Y. Buyukasik, H. Atay, E. Kelkitli, M. Turgut, O. Bektaş, E. Eliaçık, Ayşe Işık, S. Aksu, H. Goker, N. Sayınalp, O. Ozcebe, I. Haznedaroglu   +12 more
semanticscholar   +1 more source

Imatinib mesylate in the treatment of diffuse cutaneous mastocytosis.

Jornal de Pediatria, 2013
M. Morren, A. Hoppé, M. Renard, Maria Debiec Rychter, A. Uyttebroeck, P. Dubreuil, Ludovic Martin   +6 more
semanticscholar   +1 more source